Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.

Journal: Frontiers in immunology
PMID: 39650663

Abstract

BACKGROUND: Breast cancer remains a leading cause of mortality among women worldwide, emphasizing the urgent need for innovative prognostic tools to improve treatment strategies. Anoikis, a form of programmed cell death critical in preventing metastasis, plays a pivotal role in breast cancer progression.

Authors

  • Xiao Guo
    School of Pharmacy, Beihua University, Jilin, China.
  • Jiaying Xing
    School of Pharmacy, Beihua University, Jilin, China.
  • Yuyan Cao
    School of Pharmacy, Beihua University, Jilin, China.
  • Wenchuang Yang
    School of Pharmacy, Beihua University, Jilin, China.
  • Xinlin Shi
    School of Pharmacy, Beihua University, Jilin, Jilin, China.
  • Runhong Mu
    School of Basic Medical Sciences, Beihua University, Jilin, China.
  • Tao Wang
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Keywords

External Resources

Popular Topics
Recent Journals